{
  "analysis_mode": "HISTORICAL_ONLY",
  "symbol": "MET.L",
  "generated_at": "2026-01-12T05:21:37.643673Z",
  "top_card": {
    "ticker": "MET.L",
    "company_name": "Metir plc",
    "sector": "Technology",
    "market_cap_gbp": 3922669,
    "days_active": 410,
    "apex_score_100": 55,
    "confidence_score_100": 45,
    "ai_final_score_25": 11,
    "ai_strength": "MODERATE",
    "timing_regime": "EARLY_BUILD",
    "action": "WATCH",
    "thesis_one_liner": "WATCH - EARLY_BUILD timing with 55/100 opportunity score"
  },
  "enrichment": {
    "company_info": {
      "name": "Metir plc",
      "sector": "Technology",
      "industry": "Scientific & Technical Instruments",
      "exchange": "LSE",
      "market": "AIM",
      "currency": "GBP",
      "risk_tier": "High Risk",
      "current_market_cap": 3922669,
      "current_close_price": 0.885
    },
    "basics": {
      "ticker": "MET.L",
      "current_price": 0.885,
      "ath": 883.125,
      "atl": 0.007,
      "ath_date": "2020-05-04",
      "atl_date": "2024-01-02",
      "week_52_high": 1.49,
      "week_52_low": 0.54,
      "week_52_high_date": "2025-09-11",
      "week_52_low_date": "2025-04-07",
      "drawdown_from_ath_pct": 99.9,
      "data_start": "2020-01-02",
      "data_end": "2026-01-09",
      "total_bars": 1521
    },
    "latest_signal": {
      "date": "2024-11-25",
      "scan_date": "2026-01-09",
      "signal_type": "CRASH ZONE BOTTOM",
      "signal_color": "YELLOW",
      "price": 0.8,
      "drawdown_pct": 81.71,
      "ai_score": 9.0,
      "rsi": 0.0,
      "cycle_position": 0.1766,
      "holding_period_days": 410,
      "current_pnl_pct": 10.62,
      "rally_state": "pulling_back",
      "distance_from_high_pct": -30.59,
      "Rally_Count": 3,
      "days_since_last_high": 19,
      "last_high_date": "2025-12-23",
      "lock_in_reached": true,
      "lock_in_date": "2025-09-11",
      "best_rally_pct": 59.37
    },
    "best_historical_signal": {
      "signal_date": "2021-01-04",
      "signal_type": "CRASH ZONE BOTTOM",
      "signal_color": "YELLOW",
      "entry_price": 125.0,
      "peak_price": 271.875,
      "peak_date": "2021-01-19",
      "rally_pct": 117.5,
      "days_to_peak": 15,
      "ai_score": 9.0
    },
    "all_historical_signals": [
      {
        "signal_id": "MET.L_2021-01-04",
        "signal_date": "2021-01-04",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 125.0,
        "current_price": 0.885,
        "current_return_pct": -99.29,
        "best_rally_pct": 95.0,
        "best_rally_date": "2021-01-19",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -99.64,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 1833,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2022-09-08",
        "signal_date": "2022-09-08",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 33.125,
        "current_price": 0.885,
        "current_return_pct": -97.33,
        "best_rally_pct": 28.3,
        "best_rally_date": "2022-10-07",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -97.92,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 1221,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2022-09-12",
        "signal_date": "2022-09-12",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 33.125,
        "current_price": 0.885,
        "current_return_pct": -97.33,
        "best_rally_pct": 28.3,
        "best_rally_date": "2022-10-07",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -97.92,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 1217,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2022-10-12",
        "signal_date": "2022-10-12",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 26.875,
        "current_price": 0.885,
        "current_return_pct": -96.71,
        "best_rally_pct": 51.16,
        "best_rally_date": "2023-03-15",
        "rally_state": "accumulating",
        "Rally_Count": 3,
        "distance_from_high_pct": -97.82,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 1187,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2022-11-25",
        "signal_date": "2022-11-25",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 26.875,
        "current_price": 0.885,
        "current_return_pct": -96.71,
        "best_rally_pct": 51.16,
        "best_rally_date": "2023-03-15",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -97.82,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 1143,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2022-12-16",
        "signal_date": "2022-12-16",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 25.0,
        "current_price": 0.885,
        "current_return_pct": -96.46,
        "best_rally_pct": 62.5,
        "best_rally_date": "2023-03-15",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -97.82,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 1122,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2022-12-23",
        "signal_date": "2022-12-23",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 23.75,
        "current_price": 0.885,
        "current_return_pct": -96.27,
        "best_rally_pct": 71.05,
        "best_rally_date": "2023-03-15",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -97.82,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 1115,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2022-12-28",
        "signal_date": "2022-12-28",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 21.875,
        "current_price": 0.885,
        "current_return_pct": -95.95,
        "best_rally_pct": 85.71,
        "best_rally_date": "2023-03-15",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -97.82,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 1110,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2022-12-29",
        "signal_date": "2022-12-29",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 21.875,
        "current_price": 0.885,
        "current_return_pct": -95.95,
        "best_rally_pct": 85.71,
        "best_rally_date": "2023-03-15",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -97.82,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 1109,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2023-01-05",
        "signal_date": "2023-01-05",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 20.625,
        "current_price": 0.885,
        "current_return_pct": -95.71,
        "best_rally_pct": 96.97,
        "best_rally_date": "2023-03-15",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -97.82,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 1102,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2023-01-11",
        "signal_date": "2023-01-11",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 20.625,
        "current_price": 0.885,
        "current_return_pct": -95.71,
        "best_rally_pct": 96.97,
        "best_rally_date": "2023-03-15",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -97.82,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 1096,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2023-06-26",
        "signal_date": "2023-06-26",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 5.0,
        "current_price": 0.885,
        "current_return_pct": -82.3,
        "best_rally_pct": 37.5,
        "best_rally_date": "2023-06-27",
        "rally_state": "accumulating",
        "Rally_Count": 1,
        "distance_from_high_pct": -87.13,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 930,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2023-06-27",
        "signal_date": "2023-06-27",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 6.875,
        "current_price": 0.885,
        "current_return_pct": -87.13,
        "best_rally_pct": -9.09,
        "best_rally_date": "2023-06-28",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 929,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2023-06-28",
        "signal_date": "2023-06-28",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 6.25,
        "current_price": 0.885,
        "current_return_pct": -85.84,
        "best_rally_pct": -30.0,
        "best_rally_date": "2023-06-29",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 928,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2023-06-29",
        "signal_date": "2023-06-29",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 4.375,
        "current_price": 0.885,
        "current_return_pct": -79.77,
        "best_rally_pct": 0.0,
        "best_rally_date": "2023-06-30",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 927,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2023-06-30",
        "signal_date": "2023-06-30",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 4.375,
        "current_price": 0.885,
        "current_return_pct": -79.77,
        "best_rally_pct": 0.0,
        "best_rally_date": "2023-07-03",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": 0.0,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 926,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2024-03-27",
        "signal_date": "2024-03-27",
        "signal_type": "ENHANCED CRASH CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.225,
        "current_price": 0.885,
        "current_return_pct": -27.76,
        "best_rally_pct": 4.08,
        "best_rally_date": "2025-09-11",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -30.59,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 655,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2024-03-28",
        "signal_date": "2024-03-28",
        "signal_type": "ENHANCED CRASH CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.225,
        "current_price": 0.885,
        "current_return_pct": -27.76,
        "best_rally_pct": 4.08,
        "best_rally_date": "2025-09-11",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -30.59,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 654,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2024-04-04",
        "signal_date": "2024-04-04",
        "signal_type": "ENHANCED DEEP CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.225,
        "current_price": 0.885,
        "current_return_pct": -27.76,
        "best_rally_pct": 4.08,
        "best_rally_date": "2025-09-11",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -30.59,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 647,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2024-04-08",
        "signal_date": "2024-04-08",
        "signal_type": "ENHANCED DEEP CRASH-ACCUM COMBO",
        "signal_color": "PURPLE",
        "entry_price": 1.225,
        "current_price": 0.885,
        "current_return_pct": -27.76,
        "best_rally_pct": 4.08,
        "best_rally_date": "2025-09-11",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -30.59,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 643,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2024-04-09",
        "signal_date": "2024-04-09",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1.175,
        "current_price": 0.885,
        "current_return_pct": -24.68,
        "best_rally_pct": 8.51,
        "best_rally_date": "2025-09-11",
        "rally_state": "accumulating",
        "Rally_Count": 0,
        "distance_from_high_pct": -30.59,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 642,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2024-04-10",
        "signal_date": "2024-04-10",
        "signal_type": "EXTREME CRASH BOTTOM",
        "signal_color": "ORANGE",
        "entry_price": 1.05,
        "current_price": 0.885,
        "current_return_pct": -15.71,
        "best_rally_pct": 21.43,
        "best_rally_date": "2025-09-11",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -30.59,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 641,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2024-05-03",
        "signal_date": "2024-05-03",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.975,
        "current_price": 0.885,
        "current_return_pct": -9.23,
        "best_rally_pct": 30.77,
        "best_rally_date": "2025-09-11",
        "rally_state": "accumulating",
        "Rally_Count": 2,
        "distance_from_high_pct": -30.59,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 618,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2024-11-22",
        "signal_date": "2024-11-22",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.8,
        "current_price": 0.885,
        "current_return_pct": 10.62,
        "best_rally_pct": 59.37,
        "best_rally_date": "2025-09-11",
        "rally_state": "pulling_back",
        "Rally_Count": 3,
        "distance_from_high_pct": -30.59,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 415,
        "status": "historical"
      },
      {
        "signal_id": "MET.L_2024-11-25",
        "signal_date": "2024-11-25",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 0.8,
        "current_price": 0.885,
        "current_return_pct": 10.62,
        "best_rally_pct": 59.37,
        "best_rally_date": "2025-09-11",
        "rally_state": "pulling_back",
        "Rally_Count": 3,
        "distance_from_high_pct": -30.59,
        "days_since_last_high": 19,
        "lock_in_reached": true,
        "age_days": 412,
        "status": "historical"
      }
    ],
    "stats": {
      "total_signals": 25,
      "win_rate_pct": 92.0,
      "avg_rally_pct": 54.32,
      "median_rally_pct": 52.82,
      "best_rally_pct": 117.5,
      "worst_rally_pct": 0.0
    },
    "splits": [
      {
        "date": "2024-01-02",
        "ratio": "1:20",
        "ratio_value": 625.0
      }
    ],
    "split_risk": {
      "split_detected": false,
      "risk_level": "NONE",
      "confidence": "HIGH"
    },
    "data_quality": {
      "price_reliability": "RELIABLE",
      "pnl_reliability": "RELIABLE",
      "overall_confidence": "HIGH"
    },
    "risk_flags": [
      "HAS_REVERSE_SPLIT",
      "EXTREME_DRAWDOWN",
      "FREQUENT_CRASHES"
    ],
    "last_updated": "2026-01-11 18:22:57 UTC"
  },
  "decision_summary": {
    "why_it_matters": [
      "APEX 55/100 indicates strong opportunity quality",
      "Timing regime: EARLY_BUILD",
      "Historical profile: 3 rallies, 59% best run"
    ],
    "main_risk": "Confidence 45/100 - full data loaded",
    "watch_next": [
      "RNS catalysts (funding/operational updates)",
      "Volume expansion confirmation",
      "Timing regime change signals"
    ]
  },
  "triangulation": {
    "rns": {
      "has_data": true,
      "ticker": "MET.L",
      "latest": [
        {
          "title": "Fundraise",
          "announcement_date": "10th Jun 2025",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "10 Jun 2025 07:00\nRNS Number : 0972M\nMetir PLC\n10 June 2025\nTHIS ANNOUNCEMENT IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR FROM THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER OR AN INVITATION TO ACQUIRE OR DISPOSE OF ANY SECURITIES. ATTENTION IS ALSO DRAWN TO THE IMPORTANT INFORMATION AT THE END OF THIS ANNOUNCEMENT.\n10 June 2025\nMetir plc\n(\"Metir\" or the \"Company\")\nFundraise\nMetir\nplc (AIM: MET), an international developer and provider of testing solutions for unique and underserved public health and environmental markets, is pleased to announce the successful completion of a fundraise (the \"\nFundraise\n\"), arranged by the Company's Joint Broker Turner Pope Investment Limited (\"\nTPI\n\"), to raise (subject to later confirmation of the intended Director participation) up to \u00a3850,000 before expenses to support the continuing growth of the Company by way of:\n\u00b7\na placing of \u00a3780,000 with investors (the \"\nPlacing\n\") at a price of 0.65p (the \"\nPlacing Price\n\") per ordinary share of 0.001 pence each in the Company (\"\nOrdinary Shares\n\"); and\n\u00b7\nthe intended participation in the Fundraise of \u00a370,000 by certain Directors of the Company to be confirmed shortly after the expected publication of the Annual Report and Accounts for the year ended 31 December 2024 on or around 25 June 2025 (the \"\nSubscription\n\").\nUse of proceeds\nAs announced in the trading update on 29 May 2025, the cost base of the Company remains very tightly controlled and is supporting strong growth but management believes that this growth is being constrained by sub-optimal levels of working capital. The board believes that additional financing would support stronger growth and move the Company into profitability more quickly.\nThe net proceeds of the Fundraise are intended to provide capital to accelerate growth of the business including for the following purposes:\n\u00b7\nWorking capital to allow the Company to finance an increased production rate of its MicroTox\u00ae LX to improve the margin on future devices sold in accordance with an increasing order book;\n\u00b7\nFunding to integrate specialist software with the Company's Continuous Toxic Monitoring (CTM) machines (as used in Qatar) to aggregate and record data from a network of machines to a single dashboard to include machine learning (AI) capabilities;\n\u00b7\nFunding to move towards commercial testing for the Company's novel prototype Pathogen Detector in conjunction with Aptamer Group plc initially for rapid on-line detection of Cryptosporidium, the primary pathogen found in sewage polluted potable water in the UK and elsewhere;\n\u00b7\nAllow the Company to provide matching capital as often required to secure any Innovate UK or similar grants for any proprietary product development that it may apply for;\n\u00b7\nFunding to support pursuit of large projects for 24/7 monitoring of potable water in towns and cities building on and similar to our project in Qatar;\n\u00b7\nOptimisation of our PFAS (forever chemicals) market leading technology; and\n\u00b7\nSettle outstanding past due creditors.\nPlacing\nPursuant to the Placing, a total of 120,000,000 Ordinary Shares (\"\nPlacing Shares\n\") have been placed, conditional only on admission to trading on AIM (\"\nAdmission\n\"), with investors at the Placing Price, equal to the closing mid\u2010market price prior to the Placing of 0.65p on 9 June 2025 (being the last practicable date prior to this announcement). Each Placing Share will rank pari passu with existing Ordinary Shares.\nThe Placing Shares represent approximately 40.1% of the enlarged issued share capital of the Company and together with the Broker Warrants (as described below) would represent approximately 44.6% of the diluted issued share capital (assuming no other warrants or options are exercised).\nTurner Pope Investments (TPI) Limited (\"\nTurner Pope\n\" or \"\nTPI\n\") is acting as broker and placing agent to the Company and Singer Capital Markets Advisory LLP (\"\nSinger Capital Markets\n\") is acting as Nominated Adviser to the Company. Under the terms of engagement between TPI and the Company, the Company has agreed to issue to JIM Nominees Limited (as nominee on behalf of TPI) warrants to subscribe for 24,000,000 Ordinary Shares in connection with the Placing exercisable at the Placing Price for 5 years from the date of Admission (the \"\nBroker\nWarrants\n\"). The issue of the Broker Warrants is conditional upon Admission.\nIntended Participation by Directors in the Placing\nRobert Moore, Acting Executive Chairman, and Nigel Burton, Non-Executive Director, (together the \"\nParticipating Directors\n\") have indicated their intention to subscribe for, in aggregate, \u00a370,000 via the Subscription and, should the directors decide to proceed with the Subscription, the price per Placing Share will be the higher of the Pricing Price and a 10% discount to the closing price of an Ordinary Share on the business day prior to the date that the directors confirm the Subscription.\nThe intended participations by the Participating Directors are included in the aggregate Fundraise described in this announcement but they are not expected to be confirmed until shortly after the publication of the Annual Report and Accounts for the financial year ended 31 December 2024, and their notification by way of a Regulatory Information Service, on or around 25 June 2025. Should the Participating Directors decide to participate, their participation will be regarded as a related party transaction and subject to satisfying, in advance, the requirements of AIM Rule 13.\nAdmission to trading\nApplication will be made to the London Stock Exchange plc for admission of the Placing Shares totalling 120,000,000 Ordinary Shares to trading on AIM. It is expected that admission will become effective and dealings in the Placing Shares will commence at 8.00 a.m. on or around 16 June 2025.\nTotal Voting Rights\nFollowing the issue of the Placing Shares as described above, the Company's issued ordinary share capital will consist of 299,178,185 Ordinary Shares. The Company does not hold any Ordinary Shares in Treasury.\nTherefore, the above figure may be used by shareholders in the Company as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.\nCash\nFollowing the completion of the Placing, the Company's current net cash position is expected to be approximately \u00a38\n50,000 and the Company will have adequate working capital headroom to continue to operate for the foreseeable future.\nBob Moore Metir's Acting Executive Chairman & CEO, commented:\n\"The careful allocation of the additional working capital raised at current market price will enable the Company to grow the business and move towards prolonged profitability. In addition to the Company's wide range of Modern Water and Microsaic Systems' proprietary instruments, testing kits and reagents that it supplies to customers with a growing order book, the capital will enable the Company to move towards commercial returns for its newly developed products and to pursue more large toxic water testing and monitoring projects based on our success in Qatar.\nWe would like to thank our existing shareholders and new investors for the continuing support they have shown for the Company and its growth plans.\"\nThe information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.\nThis announcement contains (or may contain) certain forward-looking statements with respect to certain of the Company's and/or the Directors' current expectations and projections about future events. These statements, which sometimes use words such as \"anticipate\", \"believe\", \"intend\", \"estimate\", \"expect\" and words of similar meaning, reflect the directors' beliefs and expectations and involve a number of risks, uncertainties and assumptions that could cause actual results and performance to differ materially from any expected future results or performance expressed or implied by any such forward-looking statement. Statements contained in this announcement regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The information contained in this announcement is subject to change without notice and neither Singer Capital Markets nor TPI nor, except as required by applicable law, the Company assumes any responsibility or obligation to update publicly or review any of the forward-looking statements contained herein. You should not rely on forward-looking statements, which speak only as of the date of this announcement.\nMetir plc\nBob Moore, Acting Executive Chairman & CEO\n+44 (0) 20 3657 0050\nvia Turner Pope\nSinger Capital Markets (Nominated Adviser & Joint Broker)\nAlex Bond / Oliver Platts\n+44 (0) 20 7496 3000\nTurner Pope Investments (TPI) Limited (Joint Broker)\nAndy Thacker / James Pope\n+44 (0) 20 3657 0050\nAbout Metir\nMetir is highly experienced in the development, manufacture and supply of microelectronics instrumentation for markets requiring analytical testing in public and environmental health markets. The Company has acquired and integrated the assets of Modern Water with Microsaic Systems' technologies resulting in comprehensive water testing and other toxic testing capabilities including world leading PFAS detection technology. Metir's products and solutions are commercially available through global markets via direct sale and a network of regional and country specific distributors and partners.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nMSCUPUUAQUPAPGB"
        },
        {
          "title": "Trading Update and Growth Plan",
          "announcement_date": "2nd Dec 2025",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "2 Dec 2025 07:00\nRNS Number : 7826J\nMetir PLC\n02 December 2025\n2 December 2025\nMetir plc\n(\"Metir\",\nthe \"Group\" or the \"Company\"\n)\nTrading Update and Growth Plan\nMetir\u00a0plc (AIM: MET), the leading global provider of fast response mobile and point-of-use water and environmental testing technology,\ntoday provides a trading update ahead of its financial year ended 31 December 2025.\nTrading and order book\nThe Group has\ncontinued to build on the significant progress reported in its Interim Results on 30 September 2025. Demand is increasing, driven by growing international demand for Microtox\u00ae LX instruments, reagents and SRB sales.\nCustomer demand for LX instruments has been encouraging, and sales are in line with management expectations as reported in September 2025. Although production rates of instruments have increased during the second half of the year, the Group is nearing the limits of its current outsourced manufacturing capacity.\nMetir believes that it can secure materially higher sales volumes of instruments if\nit can increase the build and supply rate.\nThe Group is in discussions with its manufacturing partner to increase production rates in 2026.\nThis will both reduce delivery times for larger batches made to order for specific customers and simultaneously create a stock of instruments which can be used to meet short turnaround demand.\nThe growing customer base of LX and FX instruments drives demand for high-margin Microtox\u00ae reagents, but unlocking and accelerating this high-margin growth depends on scaling LX and FX unit production reliably.\nAs part of the Group's growth strategy, Metir also intends to further upgrade the LX and FX units with upgraded and easily sourced supply chain components in 2026. This will significantly improve instrument margins by facilitating increased and reliable manufacturing output.\nSales of Sulphate Reducing Bacteria (SRB) kits, which started in June 2025, give the fastest results available on the market, remain robust and are in high demand. Orders of SRB kits have increased, with customer interest rising and quotations given to over 60 companies worldwide. Again, with manufacturing nearing capacity, a key component of the kits had to be paused in Q4 for necessary upgrades to improve the reliability and efficiency of the manufacturing process to increase volumes. This will enable the Group to maximise sales of this high-margin product in January 2026, providing considerable revenue contribution.\nQatar project and GCC regional development\nOn 26 September 2025, Metir reported it had completed the final commissioning of the 27 CTM units in Qatar. Since then, a small number of instruments have given technical challenges, which are being solved quickly by the Group working through its partner Avanceon. Consequently, Metir has agreed a deferred payment schedule with Avanceon for the remaining \u00a3198k with payment due by the end of Q1 2026. This will enable an additional contract performance payment of \u00a350k to be due during the same period.\nThe majority of the installations are fully operational, and replacement reagents will be routinely supplied by Metir to allow for continuous monitoring. Due to this installation in Doha being the first major state-operated system and an important proof-of-principle site for future large-scale projects, an initial supply of reagents in Qatar is included in the contract specification with new reagent revenue expected to start during early 2027.\nDuring mid November 2025, Metir took part in a UK-backed trade mission to the Kingdom of Saudi Arabia (KSA), engaging with government-linked organisations responsible for major national water programmes. KSA has the world's largest potable water desalination capacity and has committed US$105bn to 3,300 new water projects under its Vision 2030 programme, creating one of the world's largest markets for advanced water-safety technologies. Metir is establishing a marketing team, in conjunction with our regional installation partner Avanceon, based in Riyadh, to capitalise on KSA market opportunities for real-time screening for toxins in potable desalinated water.\nMetir has also secured space on the UK Trade Pavilion at the forthcoming IFAT exhibition in Riyadh from 26-28 January 2026. IFAT is the leading regional water and waste management event and conference, with the Trade Pavilion supported by the UK Department of Business and Trade.\nGrowth and working capital\nThe Group's cash balance as of 1 December 2025 is \u00a3147k, which is slightly lower than forecast. The Group has been investing in increased manufacturing and additional payments made to our manufacturer for components required for the next batch build of LX instruments. Excluding invoices to be issued for additional LX instruments being shipped in December, current receivables are \u00a3317k. Given the invoiced sales and forecasts, the Group is comfortable that it has sufficient projected revenue and cash resources for the foreseeable future.\nThe Board considers investment in manufacturing and product development as essential. This is consistent with the Group's strategy to grow revenue streams from existing product lines while conducting near-term investment in product and supply chain enhancement to support long-term revenue and profit growth. With a new business development function recently hired, Metir is expanding its international distributor network and build on the success currently being experienced in Qatar for further CTM installations.\nBob Moore, Executive Chairman and Chief Executive Officer of Metir plc, commented:\n\"I am proud of our talented team and the progress Metir has achieved so far this year. The increased customer demand has exceeded management expectations. Looking ahead to 2026, Metir will enter the year with strong momentum in instrument sales, an expanding international footprint of installed instruments, and enhanced sales and customer support capability.\nThe Group is also seeing continued growth across Microtox\u00ae reagents and SRB product lines. Our validated technology platforms, scalable recurring-revenue model and expanding distributor network provide a solid platform for accelerated growth. Scaling manufacturing capacity is now mission-critical to meet customer demand and convert our strong commercial pipeline into revenue.\nThe Board considers 2026 as transformational and a pivotal year for growth. The Group retains the characteristics of an agile, entrepreneurial technology company, with world-class products and a pipeline of unique innovative technologies under development. The Group has invested in manufacturing growth and product development which includes use of proceeds of the successful June 2025 fund raise. Accordingly, EBITDA profitability is likely to be deferred until 2026 given our planned investment profile.\nAgainst a backdrop of tightening global regulation, rising water scarcity and increasing need for real-time monitoring, Metir is a global leader in fast-response environmental testing technologies.\n\"\n-\nEnds -\nEnquiries:\nMetir plc\nBob Moore, Executive Chairman and Chief Executive Officer\n+44 (0) 20 3657 0050\nvia TPI\nSinger Capital Markets(Nominated Adviser & Joint Broker)\nAlex Bond / Oliver Platts\n+44 (0)20 7496 3000\nTurner Pope Investments (TPI) Limited(Joint Broker)\nAndrew Thacker\u202f/ Guy McDougall\n+44 (0) 20 3657 0050\nNorthstar Communications (Investor Relations)\nSarah Hollins\n+44 (0) 113 730 3896\nAbout Metir\nMetir plc is a leading global provider of fast response, mobile and point-of-use water and environmental testing technology. Through its two established trading divisions, Modern Water and Microsaic Systems a specialist in mobile PFAS monitoring, the Company develops and supplies innovative, easy-to-use solutions that deliver rapid, accurate water and liquids quality results, helping industries, utilities and regulators monitor safety and compliance in real time.\nWith a strong focus on data-driven insight and field-ready design, Metir's technology supports critical decision-making across sectors, including environmental monitoring, public health and industrial process management.\nHeadquartered in York, UK, Metir serves worldwide customers and is dedicated to advancing water testing standards through innovative, accessible solutions.\nFor more information, please visit:\nhttps://www.metirplc.com\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nTSTEAFAFEDESFAA"
        },
        {
          "title": "CFO Appointment",
          "announcement_date": "19th Nov 2025",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "19 Nov 2025 07:00\nRNS Number : 0651I\nMetir PLC\n19 November 2025\n19 November 2025\nMetir plc\n(\"Metir\" or the \"Company\")\nAppointment of Chief Financial Officer and Business Development Team\nLeadership and commercial capability strengthened to accelerate UK and international growth\nMetir\u00a0plc (AIM: MET), the leading global provider of fast response mobile and point-of-use water and environmental testing technology, is pleased to announce the appointment of Claire Smith as Chief Financial Officer with immediate effect, alongside key hires to grow its business development function. All appointments are non-Board at this time.\nClaire brings over 25 years of financial and operational experience. Most recently, she served as Chief Executive Officer and previously as Chief Financial Officer and Company Secretary of\nZytronic plc\n,\nan AIM-listed manufacturer of touch sensor products. During her tenure, she led finance, HR and IT functions. Before her role at Zytronic, Claire held finance positions with the NAAFI and Procter & Gamble, working both in the UK and Germany.\nClaire holds a B.A. (Hons) degree in Business and Finance from Northumbria University. She qualified as a Chartered Management Accountant in 2006 and obtained a Certificate in International Cash Management in 2011.\nTo accelerate growth and capitalise on new opportunities in the UK and internationally, Metir has also established a dedicated business development function, comprising a new Business Development Manager and Technical Support Specialist. This new team will focus on driving sales of Metir's LX, FX and Continuous Toxicity Monitoring (\"CTM\") product lines and expanding the Group's international distributor network, with a target to more than double its distributor base within the next 12 months. Strengthened technical support will also enable improved customer engagement, increased instrument utilisation and reagent consumption, thereby driving higher recurring revenue.\nBob Moore, Executive Chairman and Chief Executive Officer of Metir, commented:\n\"We are delighted to welcome Claire to Metir. Her extensive financial and operational expertise will strengthen the Group's management, control and reporting, as we develop and execute our growth strategy.\nThe creation of a new business development function marks an important step in enhancing our commercial reach, expanding internationally, building a global brand and delivering long-term shareholder value.\"\n-\nEnds -\nEnquiries:\nMetir plc\nBob Moore, Executive Chairman and Chief Executive Officer\n+44 (0) 20 3657 0050\nvia TPI\nSinger Capital Markets(Nominated Adviser & Joint Broker)\nAlex Bond / Oliver Platts\n+44 (0)20 7496 3000\nTurner Pope Investments (TPI) Limited(Joint Broker)\nAndy Thacker / James Pope\n+44 (0) 20 3657 0050\nNorthstar Communications (Investor Relations)\nSarah Hollins\n+44 (0) 113 730 3896\nAbout Metir\nMetir plc is a leading global provider of fast response, mobile and point-of-use water and environmental testing technology. Through its two established trading divisions, Modern Water and Microsaic Systems, the Company develops and supplies innovative, easy-to-use solutions that deliver rapid, accurate water quality results, helping industries, utilities and regulators monitor safety and compliance in real time.\nWith a strong focus on data-driven insight and field-ready design, Metir's technology supports critical decision-making across sectors, including environmental monitoring, public health and industrial process management.\nHeadquartered in York, UK, Metir serves worldwide customers and is dedicated to advancing water testing standards through innovative, accessible solutions.\nFor more information, please visit:\nhttps://www.metirplc.com\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nBOADVLFFEFLEFBX"
        },
        {
          "title": "Advancement of PFAS detection technology",
          "announcement_date": "4th Nov 2025",
          "release_time": "7:00 am",
          "source": "RNS-R",
          "content": "4 Nov 2025 07:00\nRNS Number : 0096G\nMetir PLC\n04 November 2025\nRNS Reach\n4 November 2025\nMetir plc\n(\"Metir\" or the \"Company\")\nMetir and Swansea University advance field-ready PFAS detection technology\nSuccessful feasibility of 'Lab in a Van' solution positions Metir at the forefront of sustainable PFAS monitoring amid rising regulatory focus\nMetir plc (AIM: MET), a global leader in mobile and point-of-use water and environmental testing, announces progress in its collaboration with Swansea University to develop next-generation methods for detecting PFAS 'forever chemicals'.\nContinuing media and regulatory attention have underscored the urgent need for more effective monitoring tools, as new evidence reveals widespread PFAS contamination in water and soil, carrying significant risks to human health.\nWith authorities reviewing potential limits and clean-up mandates, the ability to detect PFAS quickly and sustainably in the field has never been more important.\nIn parallel, Metir is engaging with relevant UK authorities and industry bodies on its unique technology.\nResearch led by\u00a0Dr Ruth Godfrey\u00a0at\u00a0Swansea University\u00a0has demonstrated the feasibility of integrating portable\u00a0liquid chromatography-mass spectrometry (LCMS)\u00a0with innovative low-waste extraction materials, enabling the creation of a compact 'Lab in a Van' system. This field-deployable platform enables rapid and accurate detection of PFAS in water, soil, effluent, and biological samples on-site, significantly reducing analysis turnaround time and environmental impact compared to traditional laboratory methods. PFAS levels of health concern are so low (parts per trillion) that testing conventional grab samples is a suboptimal method because collection, transportation to, and delays at the laboratory can easily result in corrupted samples with inaccurate results.\nIt is almost certain that forms of PFAS chemicals will continue to be manufactured into the future as non-replaceable production processes for many essential applications. The waste streams of these industries will be closely controlled and monitored. Very accurate PFAS detection and measurement technologies that Metir can supply will be able to fulfil this need.\nMetir supported the programme through a three-and-a-half-year PhD sponsorship that confirmed its\u00a0proprietary mass spectrometry platform\u00a0can identify a broader range of PFAS compounds with exceptional accuracy and sensitivity. Successful field trials on a Welsh river in\u00a0April 2025\u00a0validated the technology's real-world capability. Metir continues to collaborate with its\u00a0large US-based distribution and instrumentation partner\u00a0to optimise and scale the detector for potential commercial deployment, particularly in the US market. A recent visit to the partner's facilities in the US confirms the progress being made.\nBy combining Swansea University's academic excellence with Metir's expertise in sustainable mobile testing solutions, the partnership is advancing a vital tool for addressing one of the world's most persistent environmental challenges. These innovations will help regulators, utilities, and industries meet increasingly stringent environmental standards and enhance public health protection against PFAS exposure.\nBob Moore, Executive Chairman and Chief Executive Officer of Metir plc, said:\n\"PFAS contamination is one of today's most pressing environmental and health challenges. Our partnership with Swansea University and collaboration with our US partner accelerates the development of practical, scalable detection technologies while creating a strong commercial opportunity for Metir. This is a clear example of our strategy to turn cutting-edge science into field-ready solutions.\"\nDr Ruth Godfrey, Associate Professor in LCMS at Swansea University, added:\n\"Our research focuses on translating laboratory excellence into practical technologies. Partnering with Metir allows us to create deployable systems that address urgent monitoring needs and provide a sustainable route to tackling the PFAS problem at scale.\"\n-\nEnds -\nMetir plc\nBob Moore, Executive Chairman and Chief Executive Officer\n+44 (0) 20 3657 0050\nvia Turner Pope\nSinger Capital Markets (Nominated Adviser & Joint Broker)\nAlex Bond / Oliver Platts\n+44 (0) 20 7496 3000\nTurner Pope Investments (TPI) Limited (Joint Broker)\nAndy Thacker / James Pope\n+44 (0) 20 3657 0050\nNorthstar Communications (Investor Relations)\nSarah Hollins\n+44 (0) 113\n730 3896\nAbout Metir\nMetir plc is a leading global provider of mobile and point-of-use water and environmental testing technology. Through its two established divisions, Modern Water and Microsaic Systems, the Company develops and supplies innovative, easy-to-use solutions that deliver rapid, accurate water quality results, helping industries, utilities and regulators monitor safety and compliance in real time.\nWith a strong focus on data-driven insight and field-ready design, Metir's technology supports critical decision-making across sectors, including environmental monitoring, public health and industrial process management.\nHeadquartered in York, UK, Metir serves worldwide customers and is dedicated to advancing water testing standards through innovative, accessible solutions.\nFor more information, please visit\nhttps://www.metirplc.com\nThis information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nNRAEANFDEDLSFFA"
        },
        {
          "title": "Half-year Report",
          "announcement_date": "30th Sep 2025",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "30 Sep 2025 07:00\nRNS Number : 2894B\nMetir PLC\n30 September 2025\n30 September 2025\nMetir plc\n(\"Metir\" or the \"Group\")\nInterim Results for the six months ended 30 June 2025\nPreparing for growth\nMetir\u00a0plc (AIM: MET), the\nleading global provider of fast response mobile and point-of-use water and environmental\ntesting technology\n, today announces its unaudited interim\nresults for the six months ended 30 June 2025\n(\"H1 25\").\n\u00a3'000s\nH1 25\nH1 24 *\nRevenue\n919\n111\nGross profit\n352\n43\nGross margin\n38.3%\n38.7%\nOperating expenses\n656\n674\nEBITDA\n(261)\n(556)\nProfit/(Loss)\n(304)\n(631)\nCash balance at 30 June\n585\n982\n* H1 24 revenues restated to defer \u00a3144k of Qatar CTM revenues to H1 25 to reflect delay in commissioning\nFinancial highlights\n\u00b7\nRevenue increased 828% to \u00a3919k (H1 2024: \u00a3111k), reflecting strong sales momentum following the 2024 reset.\n\u00b7\nMicrotox\u00ae LX instrument sales increased to \u00a3368k (H1 2024: \u00a340k).\n\u00b7\nReagent revenue increased to \u00a3117k (H1 2024: \u00a341k), including approximately \u00a326k of reagent revenue from three previously installed and active continuous monitoring (\"CTM\") installations in Hungary and Poland.\n\u00b7\nThe flagship Qatar project contributed revenue of \u00a3386k, with project CTMs now successfully commissioned.\n\u00b7\nGross profit margin remained steady at c.38%, with reagents delivering the highest margin at over 70% and LX instruments the lowest margin at 18% (see below).\n\u00b7\nOperating expenses of \u00a3656k are in line with the prior year, reflecting the strong control of costs as the business was stabilised.\n\u00b7\nAdjusted EBITDA loss reduced to \u00a3(261k), a 54% improvement from the prior year,\ndriven by higher revenues and gross profit.\n\u00b7\nLoss reduced to \u00a3(304k), more than halved from the prior year,\ndriven by higher revenues and gross profit.\n\u00b7\nCash balance of \u00a3585k compared to \u00a3982k in the prior period as a result of the successful fundraise of\n\u00a3780k\non 10 June 2025.\nOperational highlights\n\u00b7\nCompletion of strategic reset in 2024 and a clear platform established for future revenue growth.\n\u00b7\nRebranded to Metir plc in February 2025, aligning with the Group's strategic vision to integrate Microsaic Systems' and Modern Water's technologies.\n\u00b7\nAppointment of Dr Christopher Potts as Independent Non-Executive Director in February 2025, strengthening Board oversight and governance.\n\u00b7\nLaunch of Sulphate Reducing Bacteria (\"SRB\") kits in late June 2025, creating a new revenue stream from H2 2025.\n\u00b7\nField development of proprietary mobile PFAS \"forever chemicals\" mobile testing platform in partnership with Swansea University completed, and initial product testing with US technology partner expected to be finalised at the end of the year.\n\u00b7\nDuring the installation of 27 new CTM instruments in Qatar, the systems were also upgraded with enhanced software to deliver improved real-time data recording.\nPost period end\n\u00b7\nSigned collaboration agreement with Aptamer Group plc in September 2025 to develop Optimer\n\u00ae binders for the Group's Pathogen Detector, enabling real-time monitoring of Cryptosporidium parvum in drinking water.\n\u00b7\nAs announced on 26 September 2025, the Group has received confirmation from its partner, Avanceon in Qatar, that the state water authority,\nKahramaa, has granted final approval for all the CTMs installations. This activates the final project payment of \u00a3198k, with the total due within 60 days of the announcement.\nOutlook\nsummary\n\u00b7\nChanging market dynamics mean mission-critical technology and validated global platforms position Metir at the forefront of tightening regulation.\n\u00b7\nFocus on accelerating sales growth and improving gross margins, with a group gross margin target of\u00a060%\n.\n\u00b7\nRoll-out of LX, FX and CTM instruments through strengthened sales and distributor\nstrategy\u00a0which in turn drives\u00a0higher-margin\u00a0and repeat\u00a0reagent revenues.\n\u00b7\nBuild on Qatar success\u00a0with\u00a0new CTM projects\u00a0currently being evaluated\u00a0in other cities and industrial plants.\n\u00b7\nStrong progress with PFAS mobile testing and Pathogen Detector prototype development, opening new market opportunities.\n\u00b7\nContinued focus on governance and cost control\u00a0with\u00a0the recruitment of a senior finance leader to support growth.\n\u00b7\nDecision to focus on investing in infrastructure and product development during the next 12 months to accelerate long-term sales growth, profitability, and cash generation.\nA copy of these interim results is being made available on the Group's website at\nhttps://www.metirplc.com/investors/#documents,\nand hard copies will be sent to shareholders who have requested communications in that format.\nBob Moore, Executive Chairman and Chief Executive Officer, Metir plc, commented:\n\"The first half of 2025 has been a pivotal period for Metir, marking the Group's return to growth following the acquisition of the Modern Water business and the comprehensive strategic reset undertaken in 2024. Revenue increased to \u00a3919,000, driven by strong demand for our Microtox\u00ae LX instruments, higher reagent sales and the revenue from the Group's flagship Qatar Continuous Toxicity Monitors (CTM) project.\nThe recently announced deployment and commissioning of the CTM project in Qatar is a major step forward. This high-profile installation project gives us a strategic foothold in the Middle East and demonstrates the Group's ability to deliver large-scale, real-time water quality monitoring solutions. Alongside this, the Group has broadened its product portfolio with the launch of SRB kits, commenced production of its portable Microtox\u00ae FX units, and advanced two key technology initiatives, the Pathogen Detector and the Group's mobile PFAS testing platform, both of which have the potential to redefine environmental testing capabilities with rapid early warning results.\nLooking ahead, the Group is encouraged by strong sales momentum with a clear plan to accelerate growth in 2026. With the recent launch of the SRB kits and FX instruments, the second half of 2025 is also expected to meet management's sales expectations. With environmental regulation tightening globally, increasing water scarcity, quality issues and climate pressures driving demand for real-time and mobile testing, Metir's fast response field-ready technology is well placed to provide proven solutions to industries, utilities and regulators worldwide.\nWith a realisable plan for growth supported by prudent further investment, the Group is focusing on its objective to drive commercialisation, increase gross margins and deliver sustainable long-term value for shareholders.\"\n-\nEnds -\nMetir plc\nBob Moore, Executive Chairman and Chief Executive Officer\n+44 (0) 20 3657 0050\nvia Turner Pope\nSinger Capital Markets (Nominated Adviser & Joint Broker)\nAlex Bond / Oliver Platts\n+44 (0) 20 7496 3000\nTurner Pope Investments (TPI) Limited (Joint Broker)\nAndy Thacker / James Pope\n+44 (0) 20 3657 0050\nNorthstar Communications (Investor Relations)\nSarah Hollins\n+44 (0) 113\n730 3896\nAbout Metir\nMetir plc is a leading global provider of fast response, including mobile, point-of-use water and environmental testing technology. Through its two established trading divisions, Modern Water and Microsaic Systems, the Group develops and supplies innovative, easy-to-use solutions that deliver rapid, accurate water quality results, helping industries, utilities and regulators monitor safety and compliance in real time.\nWith a strong focus on data-driven insight and field-ready design, Metir's technology supports critical decision-making across sectors, including environmental monitoring, public health and industrial process management.\nHeadquartered in York, UK, Metir serves worldwide customers and is dedicated to advancing water testing standards through innovative, accessible solutions.\nFor more information, please visit\nhttps://www.metirplc.com\nChairman and Chief Executive Officer's Statement\nThe first half of 2025 has marked a turning point for Metir plc, as the operational and financial transformation initiated in 2024 has begun to deliver clear, measurable results.\nFollowing a year of strategic reset and consolidation, the business has returned to growth with revenue of \u00a3919k for the six months ended 30 June 2025 (H1 2024: \u00a3111k), underpinned by strong demand for our Microtox\u00ae LX instruments, increased reagent sales and the recognition of revenue from the Group's flagship Qatar project.\nThe successful deployment and commissioning of the CTMs project in Qatar represents a major operational milestone, cementing a strategic foothold in the Middle East and demonstrating the Group's capability to deliver large-scale, real-time water quality monitoring solutions. This project not only strengthens the Group's market presence but also positions Metir at the forefront of global water safety and regulatory compliance, which we expect to replicate elsewhere.\nThe Group's product portfolio has expanded with the June 2025 launch of SRB kits, creating a new revenue stream to be recognised in the second half. Production of the Group's Microtox\u00ae FX portable units is now underway, complementing the established LX range and driving additional reagent demand.\nThe Group continues to make further progress on its proprietary PFAS (forever chemicals) mobile testing platform in collaboration with Swansea University and a US technology partner\n.\nThese technologies have the potential to define the next generation of environmental testing solutions.\nPost period end in September 2025, the Group signed an agreement with Aptamer Group plc, which represents a significant step forward in the commercialisation of our real-time Pathogen Detector platform. By integrating Aptamer's Optimer\u00ae technology for the rapid detection of\nCryptosporidium parvum\n, the Group is advancing one of the final technical stages required to take the Pathogen Detector from prototype to commercial readiness. This innovative collaboration is expected to deliver proof-of-concept within months and position Metir at the forefront of next-generation water quality monitoring, addressing a critical global public health need and creating a strong commercial opportunity in a growing market.\nThe strengthened governance, rebranding to Metir plc, and prudent investment in infrastructure, manufacturing, and commercial capability, supported by the \u00a3780,000 net proceeds from the Group's June 2025 fundraising and an additional Directors' contribution of \u00a370,000 to the fundraise, have enhanced the Group's ability to scale production, accelerate product commercialisation and expand internationally.\nOutlook\nThe Group is encouraged by strong sales momentum with a clear plan to accelerate growth in 2026. With the recent launch of the SRB kits and FX instruments, the second half of 2025 is also expected to meet management's sales expectations. Expansion of the sales and business development function will support the international roll-out of LX, FX and CTM instruments through a targeted distributor strategy. Increased adoption of these instruments is expected to drive higher-margin reagent revenues. With sales concentrated through a limited number of international distributors, there remain significant growth opportunities for international market growth.\nBuilding on the progress achieved in Qatar, the Group intends to pursue further projects and CTM installations in other cities and industrial plants. The Group will be participating in a UK regional trade mission in Saudi Arabia and Bahrain during November 2025 as part of this marketing strategy.\nManagement also believes it can deliver greater gross margins from the future sales of LX machines with further investment and development of the hardware electronics. The Board has set a group gross margin target of 60% underpinned by LX cost reductions and continued growth in reagent sales. Plans to achieve this are being developed and will be presented to shareholders in due course.\nAt the same time, Metir is making strong progress on its innovation pipeline. The development of the PFAS mobile testing platform, with successful field tests completed and the Pathogen Detector prototype development, represents a major opportunity to enter new markets and respond to growing global demand for next-generation environmental testing technologies.\nThe Board will also continue to focus on governance and cost control as it looks to invest in further growth. To support this, the management team will be strengthened with a senior finance appointment.\nThe Board is encouraged by the Group's progress and believes a significant growth opportunity exists for its products.\nWith mission-critical technology, a validated global platform, and a recurring revenue model, Metir is positioned at the forefront of tightening environmental regulation, increasing water scarcity, and climate-driven pressures. Demand for real-time, mobile water quality testing continues to grow, and Metir's rapid response field-ready technology provides proven solutions to industries, utilities, and regulators worldwide.\nTo accelerate this opportunity and deliver greater long-term value for shareholders, the Board has decided\nto focus on investing in infrastructure and product development during the next 12 months to accelerate long-term sales growth, profitability, and cash generation. The\nGroup looks forward to updating shareholders on the execution of this growth strategy.\nSTATEMENT OF COMPREHENSIVE INCOME (UNAUDITED)FOR THE SIX MONTHS ENDED 30 JUNE 2025\n6 months\n6 months\nYear to 31\nto 30 June\nto 30 June\nDecember\n2025\n2024\n2024\nNotes\nUnaudited\nUnaudited\nAudited\n\u00a3000s\n\u00a3000s\n\u00a3000s\nRevenue\n4\n919\n111\n232\nCost of sales\n5\n(567)\n(68)\n(357)\nGross profit\n352\n43\n(125)\nOther operating income\n-\n-\n-\nOther operating expenses\n(656)\n(674)\n(1,590)\nTotal operating expenses\n(656)\n(674)\n(1,590)\nLoss from operations before share-based payments\n(304)\n(631)\n(1,715)\nShare-based payments\n11\n-\n-\n-\nLoss from operations after share-based payments\n(304)\n(631)\n(1,715)\nOther financial cost\n-\n-\n(384)\nFair value gain to other financial costs\n-\n-\n152\nFinance cost\n-\n-\n-\nFinance income\n-\n16\n25\nLoss before tax\n(304)\n(615)\n(1,922)\nTax on loss on ordinary activities\n-\n-\n113\nTotal comprehensive loss for the period\n(304)\n(615)\n(1,809)\nLoss per share attributable to the equity holders of\nthe Company\nBasic and diluted loss per ordinary shares\n6\n(0.16)p\n(0.37)p\n(1.05)p\nSTATEMENT OF FINANCIAL POSITION (UNAUDITED)\nAS AT 30 JUNE 2025\n30 June\n30 June\n31 December\n2025\n2024\n2024\nNotes\nUnaudited\nUnaudited\nAudited\n\u00a3000s\n\u00a3000s\n\u00a3000s\nASSETS\nNon-current assets\nIntangible assets\n149\n75\n142\nProperty, plant and equipment\n47\n133\n68\nRight of use assets\n-\n-\n-\nTotal non-current assets\n196\n208\n210\nCurrent assets\nInventories\n46\n265\n193\nTrade and other receivables\n575\n491\n695\nCorporation tax receivable\n-\n-\n113\nCash and cash equivalents\n585\n982\n188\nTotal current assets\n1,206\n1,738\n1,189\nTOTAL ASSETS\n1,402\n1,946\n1,399\nEQUITY AND LIABILITIES\nEquity\nShare capital\n1,734\n1,748\n1,733\nShare premium\n30,812\n30,095\n30,110\nShare-based payment reserve\n-\n-\n-\nRetained losses\n(31,963)\n(30,465)\n(31,659)\nTotal Equity\n583\n1,378\n184\nCurrent liabilities\nTrade and other payables\n566\n531\n962\nLease liability\n19\n18\n19\nFinancial Liability\n232\n-\n232\nTotal current liabilities\n817\n549\n1,213\nNon-current liabilities\nProvision\n9\n2\n19\n2\nLease liability\n-\n-\n-\nTotal non-current liabilities\n2\n19\n2\nTotal liabilities\n819\n568\n1,215\nTOTAL EQUITY AND LIABILITIES\n1,402\n1,946\n1,399\nSTATEMENT OF CHANGES IN EQUITY (UNAUDITED) AS AT 30 JUNE 2025\nShare\nbased\nShare\nShare\npayment\nRetained\nTotal\ncapital\npremium\nreserve\nLosses\nequity\n\u00a3000s\n\u00a3000s\n\u00a3000s\n\u00a3000s\n\u00a3000s\nAt 1 January 2024\n1,731\n28,263\n-\n(29,850)\n144\nTotal comprehensive loss for the period\n-\n-\n-\n(615)\n(615)\nTransactions with owners\nShares issued\n2\n2,112\n-\n-\n2,114\nShare issue costs\n-\n(265)\n-\n-\n(265)\nShare based payments share options\n-\n-\n-\n-\n-\nAt 30 June 2024\n1,733\n30,110\n-\n(30,465)\n1,378\nAt 1 July 2024\n1,733\n30,110\n-\n(30,465)\n1,378\nTotal comprehensive loss for the period\n-\n-\n-\n(1,194)\n(1,194)\nTransactions with owners\nTransfer in respect of directors' warrants exercised\n-\n-\n-\n-\n-\nTransfer in respect of lapsed share options\n-\n-\n-\n-\n-\nShare based payments-share options\n-\n-\n-\n-\n-\nAt 31 December 2024\n1,733\n30,110\n-\n(31,659)\n184\nAt 1 January 2025\n1,733\n30,110\n-\n(31,659)\n184\nTotal comprehensive loss for the period\n-\n-\n-\n(304)\n(304)\nTransactions with owners\nTransfer in respect of lapsed share options\n-\nShares issued\n1\n779\n-\n-\n780\nShares issued costs\n(77)\n-\n-\n(77)\nAt 30 June 2025\n1,734\n30,812\n-\n(31,963)\n583\nSTATEMENT OF CASH FLOWS (UNAUDITED)FOR THE SIX MONTHS ENDED 30 JUNE 2025\n6 months\n6 months\nYear to 31\nto 30 June\nto 30 June\nDecember\n2025\n2024\n2024\nNotes\nUnaudited\nUnaudited\nAudited\n\u00a3000s\n\u00a3000s\n\u00a3000s\nCash flows from operating activities\nCash absorbed by operations\n12\n(390)\n(1,186)\n(1,917)\nCorporation tax received\n113\n262\n262\nNet cash used in operating activities\n(277)\n(924)\n(1,655)\nCash flows from investing activities\nPurchases of intangible assets\n(29)\n(38)\n(122)\nPurchases of property, plant and equipment\n-\n(90)\n(78)\nProceeds from sale of Non-current assets\nInterest received\n-\n-\n-\n16\n-\n25\nNet cash used in investing activities\n(29)\n(112)\n(175)\nCash flows from financing activities\nProceeds from share issues\n780\n2,112\n2,112\nShare issue costs\n(77)\n(265)\n(265)\nRepayment of lease liabilities\n-\n(2)\n(2)\nNet cash from/(used in) financing activities\n703\n1,845\n1,845\nNet increase/(decrease) in cash and cash equivalents\n397\n809\n15\nCash and cash equivalents at beginning of the year\n188\n173\n173\nCash and cash equivalents at the end of the period\n585\n982\n188\nNOTES TO THE INTERIM FINANCIAL INFORMATION (UNAUDITED)\n1. Nature of Operations\nMetir plc (the \"Company\") is registered in England and Wales. The Company's registered office is at York Eco Business Centre, Amy Johnson Way, York, England YO30 4AG. The Company has two wholly (100%) owned subsidiaries, Modern Water (U.K.) Ltd and Microsaic Systems Trading Ltd, so the financial information relates to these consolidated accounts together with the parent company. Metir is a high technology company\nsupplying Modern Water analytical instruments utilising the MicroTox\u00ae bio-reagent brand manufactured at our new dedicated laboratory near York, England. The Company also manufactures miniaturised\nmass spectrometers that are designed to be utilised at point-of-need testing which can be used complimentary to Modern Water technologies including PFAS detection.\n2.\nBasis of preparation\nThe interim financial statements of the Company for the six months ended 30 June 2025, which are unaudited, have been prepared in accordance with the accounting policies set out in the annual report and accounts for the year ended 31 December 2024, which were prepared under International Financial Reporting Standards (\"IFRS\").\nThis report does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006 and has not been audited. The financial information for the full preceding year is based on the statutory accounts for the year ended 31 December 2024. Those statutory accounts have been published and have been filed with the Registrar of Companies. The auditor's report on those statutory accounts was unqualified.\nAs permitted, this interim report has been prepared in accordance with the AIM Rules for Companies and not in accordance with IAS 34 \"Interim Financial Reporting\" and therefore it is not fully compliant with IFRS.\nThe interim financial statements are presented in pounds sterling.\n3.\nCritical accounting estimates and judgements\nAccounting estimates and judgements are continually evaluated and are based on past experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.\nThe Company makes estimates and assumptions concerning the future. The resulting accounting estimates could, by definition, differ from the actual outcome.\nEstimates and adjustments that have a risk of causing a material adjustment to the carrying amounts of assets and liabilities are set out in the annual report and accounts for the year ended 31 December 2024, and no additional items have been identified.\n4.\nRevenues\nIFRS 15 provides a single, principles based, five-step model to be applied to all contracts with customers. The five-step framework includes:\n\u00b7\nIdentify the contract(s) with a customer;\n\u00b7\nIdentify the performance obligations in the contract;\n\u00b7\nDetermine the transaction price;\n\u00b7\nAllocate the transaction price to the performance obligations in the contract; and\n\u00b7\nRecognise revenue when the entity satisfies a performance obligation.\nThe Company recognises revenue from the following four sources:\n\u00b7\nSale of products;\n\u00b7\nSale of consumables and spare parts;\n\u00b7\nProduct service and product support; and\n\u00b7\nConsultancy services.\nAll revenues and trade receivables arise from contracts with customers. Revenue is measured based on the consideration which the Company expects to be entitled in a contract with a customer and excludes amounts collected on behalf of third parties. The sale of products, consumables and spare\nparts are recognised when the sole performance obligation is met which is usually on delivery to the customer. For product service, product support and consultancy services revenue, the performance obligation is satisfied over the duration of the service period and revenue is recognised in line with the satisfaction of the performance obligation.\nSale of products\nThe Company sells a wide range of Modern Water analytical and toxic water and effluent testing equipment utilising our MicroTox\u00ae consumable bio-reagents. The Company also sells mini mass spectrometers (Microsaic 4500 MiD\u00ae) mainly through OEMs and distributors. A small proportion of its sales are direct to the customer. Discounts are offered and agreed as part of the contractual terms. Terms are generally Ex Works so control passes when the customer collects the goods. Payment terms are generally 30 days from the date of invoice.\nSales of consumables and spare parts\nThe Company sells consumables and spare parts mainly through OEMs and distributors. Terms are generally Ex Works so control passes when the customer collects the goods. Discounts are offered and agreed as part of the contractual terms. Payment terms are generally 30 days from the date of invoice.\nProduct service and product support revenue\nService and support to our OEMs, distributors and systems integrators includes training their sales and service teams and servicing the products from time to time. Discounts are offered and agreed as part of the contractual terms. Terms are Ex Works so control passes when the customer receives the service. Payment\nterms are generally 30 days from the date of invoice.\nUsually, there is no obligation on the Company for returns, refunds or similar arrangements. Also, the Company does not manufacture specific items to a customer's specification and no financing component is included in the terms with customers.\nThe Company provides assurance warranties which are 15 months from the date of shipment for OEMs and distributors. These warranties confirm that the product complies with agreed-upon specifications. The Company is looking to provide service warranties in the future to direct customers in Europe, where the revenue from such warranties will be recognised over the period of the service agreement.\nConsultancy services revenue\nConsultancy services comprise science and engineering consultancy, laboratory services and monitoring services. These services are delivered over a period of time usually in accordance with a master services agreement and/or statement of works with an agreed outcome at the end of the project or project phase.\nConsultancy services revenue is recognised by reference to the stage of completion of the project or project phase at the balance sheet date as follows:\n\u00b7\nWhere there are defined project or project phase milestones, the revenue is recognised in full on completion of the project or project phase and on a time basis for the stage of completion where the project or project phase is not completed at the balance sheet date. The stage of completion is recognised as the proportion of time spent on the project or project phase compared with the total time anticipated to complete the project or project phase; and/or\n\u00b7\nWhere the project is defined with the client in terms of time spent, the revenue is recognised on the basis of consulting time spent on the project by the Company at the time-based rates agreed with the client.\nThe geographical analysis of revenues (by location of shipment) was as follows:\n6 months\n6 months\nYear to 31\nto 30 June\nto 30 June\nDecember\n2025\n2024\n2024\nUnaudited\nUnaudited\nAudited\n\u00a3000s\n\u00a3000s\n\u00a3000s\nUK\n12\n3\n11\nUSA\n69\n70\n97\nEU\n142\n23\n42\nChina\n19\n-\n14\nROW\n677\n15\n68\n919\n111\n232\nThe product group analysis of revenues was as follows:\n6 months\n6 months\nYear to 31\nto 30 June\nto 30 June\nDecember\n2025\n2024\n2024\nUnaudited\nUnaudited\nAudited\n\u00a3000s\n\u00a3000s\n\u00a3000s\nProduct/Unit\n783\n54\n84\nConsumables and spares\n131\n43\n118\nService and support income\n5\n14\n30\nTotal Sales to customers\n919\n111\n232\n5.\nCost of sales\nCost of sales of products\nThe cost of sales of Modern Water, mass spectrometers and related equipment is the bought in purchase cost of the product or the transfer value from stock value if an item has been previously written down. Usually, the sale is made on an Ex-Works basis but if it were not the cost of delivery to the customer is also included in cost of sales.\nCost of sales of consumables and spare parts\nThe cost of sales of consumable and spare parts is the bought in purchase cost of the consumable or spare part or the transfer value from stock value if an item has been previously written down. Usually, the sale is made on an Ex-Works basis but if it were not the cost of delivery to the customer is also included in cost of sales.\nCost of sales of product service and product support income\nThe cost of sales of service and support income is the time-based apportionment of the employment costs of the relevant staff spent on the delivery of the service and support income plus any related costs of fulfilment such as travel expenses and any externally incurred direct costs. For the purposes of cost of sales, the employment costs are considered to be salaries, pensions and employers national insurance but does not include share-based payments nor any apportionment of training or overheads.\nCost of sales of consultancy services revenue\nThe cost of sales of consultancy services (comprising science and engineering consultancy, laboratory services and monitoring services) is the time-based apportionment of the employment costs of the relevant staff spent on the delivery of this revenue plus any related costs of fulfilment such as travel expenses and any externally incurred direct costs. For the purposes of cost of sales, the employment costs are considered to be salaries, pensions and employers national insurance but does not include share-based payments nor any apportionment of training or overheads.\n6.\nLoss per share\n6 months\n6 months\nYear to 31\nto 30 June\nto 30 June\nDecember\n2025\n2024\n2024\nUnaudited\nUnaudited\nAudited\nComprehensive loss attributable to equity\n(304)\n(615)\n(1,809)\nshareholders (\u00a3000s)\nWeighted average number of ordinary\nshares for the purpose of basic\n192,364,998\n164,321,042\n172,695,993\nand diluted loss per share\nBasic and diluted loss per ordinary share (p)\n(0.16)p\n(0.37)p\n(1.05)p\n7.\nEBITDA Adjusted Loss\nA key indicator of performance for the Company is Adjusted EBITDA Loss (Loss of earnings before interest, tax, depreciation, amortisation and other items such as share-based payments and exceptional one-off expenditure). Detailed below is the Adjusted EBITDA Loss for the period:\n6 months\n6 months\nYear to\nto 30 June\nto 30 June\n31-Dec\n2025\n2024\n2024\nUnaudited\nUnaudited\nUnudited\n\u00a3000s\n\u00a3000s\n\u00a3000s\nComprehensive loss for period\n(304)\n(615)\n(1,809)\nAdjust for:\nTax on loss on ordinary activities\n-\n-\n(113)\nDepreciation of property, plant and equipment\n21\n60\n124\nDepreciation of right of use assets\n-\n-\nAmortisation of Intangibles\n22\n15\n34\nNet finance cost/(income)\n-\n(16)\n(25)\nShare-based payments (excluding fee shares)\n-\n-\n-\nEBITDA Adjusted Loss\n(261)\n(556)\n(1,789)\n8.\nEmployees and employment related costs\n6 monthsto 30 June\n6 monthsto 30 June\nYear to 31December\n2025\nUnaudited\n2024\nUnaudited\n2024\nAudited\nStaff Numbers\nDirectors\n2\n2\n2\nOther staff\n2\n-\n2\nAverage Headcount\n4\n2\n4\n\u00a3000s\n\u00a3000s\n\u00a3000s\nEmployment costs (including Directors)\nWages and salaries\n98\n110\n264\nSocial security costs\n6\n8\n16\nTermination payments\n-\n-\n-\nPension costs\n5\n10\n15\nEmployment related share-based payments\n-\n-\n-\n109\n128\n295\n9.\nProvisions\nDilapidations\nWarranties\nTOTAL\n\u00a3000s\n\u00a3000s\n\u00a3000s\nBalance at 1 January 2025\n0\n2\n2\nProvided for/(reduced) during the period\n-\n-\n-\nBalance at 30 June 2025\n0\n2\n2\n10.\nCommitments\nAs at 30 June 2025, purchase commitments relating to purchase orders placed on, and related contractual arrangements and obligations, with our third-party manufacturers amounted to \u00a3349,800 (31 December 2024: \u00a3104,400).\n11.\nShare-based payments\nThe share-based payments charge comprises\n6 months\n6 months\nYear to\nto 30 June\nto 30 June\n31 December\n2025\n2024\n2024\nUnaudited\nUnaudited\nAudited\n\u00a3000s\n\u00a3000s\n\u00a3000s\nDirectors' fees settled in shares\n-\n-\n-\nVesting of share options\n-\n-\n-\nEmployment related share-based payments\n-\n-\n-\nBrokers' fees settled in shares\n-\n-\n-\n-\n-\nThere were no Directors' fees settled in shares in the 6 month period to 30 June 2025.\n12.\nCash absorbed by operations.\n6 months\n6 months\nYear to 31\nto 30 June\nto 30 June\nDecember\n2025\n2024\n2024\nUnaudited\nUnaudited\nAudited\n\u00a3000s\n\u00a3000s\n\u00a3000s\nTotal comprehensive loss for the year\n(304)\n(615)\n(1,809)\nAdjustments for:\nAmortisation of intangible assets\n22\n15\n34\nDepreciation of right of use assets\n-\n-\n-\nDepreciation of property, plant and equipment\n21\n60\n124\nTransfer of property, plant and equipment to\n-\n-\n-\ncost of goods\nLoss/(Profit) on disposal of right of use assets\n-\n-\n-\nRecognition of other financial liability\n-\n-\n384\nFair value movement on other financial liability\n-\n-\n(152)\nIncrease/(Decrease) in provision for expected\n-\n-\n-\ncredit losses\n-\n-\n-\nShare-based payments (inclusive of fees settled in shares)\nIncrease/(Decrease) in inventory provision\n-\n-\nTax on loss on ordinary activities\n-\n(113)\nInterest on lease liability\n-\n-\n-\nInterest received\n-\n(16)\n(25)\nMovements in working capital:\nIncrease/(Decrease) in inventories\n147\n(162)\n(90)\n(Increase)/Decrease in trade and other receivables\n120\n(480)\n(688)\nIncrease/(Decrease) in trade and other payables\n(396)\n12\n60\n(Decrease) in provisions for\ndilapidations & warranty\n-\n-\n(28)\nIncrease/(Decrease) in contract Liabilities\n-\n-\n386\nCash absorbed by operations\n(390)\n(1,186)\n(1,917)\n13. Related party transactions\nThere were no related party transactions in the six months ended 30 June 2025. Mr Bob Moore and Dr. Nigel Burton, as Participating Directors, subscribed for 10,727,969 ordinary shares of 0.001 pence for an aggregate of \u00a370,000 via the Subscription following the period end as announced at the time of the Fundraise on 10 June 2025.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nIR QKLFLEKLXBBD"
        }
      ],
      "themes": [
        "funding",
        "operations"
      ]
    },
    "social": {
      "has_data": true,
      "buzz_level": "HIGH",
      "post_count": 375,
      "sentiment_breakdown": {
        "positive": 0.0,
        "neutral": 100.0,
        "negative": 0.0
      }
    },
    "trends": {
      "has_data": true,
      "current_interest": 0,
      "momentum_score": 211.64,
      "trend_direction": "UP",
      "intelligence_signal": "DEAD_TICKER",
      "activity_level": "DEAD"
    },
    "volatility": {
      "atr_normalized": null,
      "stddev_20d": null
    },
    "risk_flags": {
      "split_risk_level": "NONE",
      "halt_risk": "NONE",
      "penny_stock_risk": "NONE"
    }
  },
  "ai_insights": {
    "available": false,
    "reason": "LLM module not loaded or analysis failed"
  },
  "scoring_breakdown": {
    "apex_factors": [
      "Technical quality: +11 (AI_Technical_Score=9.0/20)",
      "Drawdown reversion potential: +16 (Drawdown_Pct=81.7%)",
      "Volume confirmation: +10 (Relative_Volume=3.5)",
      "Pattern reliability: +10 (Rally_Count=3.0)",
      "Upside history: +8 (best_rally_pct=59%)"
    ],
    "technical_score": {
      "points": 11,
      "ai_score": 9.0,
      "reason": "AI Technical Score 9.0/20 translates to 11/25 points"
    },
    "drawdown_score": {
      "points": 16,
      "drawdown_pct": 81.71,
      "reason": "Drawdown of 81.7% gives 16/20 points"
    },
    "volume_score": {
      "points": 10,
      "rel_volume": 3.45,
      "reason": "Relative volume 3.45x gives 10 points"
    },
    "pattern_score": {
      "points": 10,
      "rally_count": 3.0,
      "reason": "3.0 historical rallies gives 10/15 points"
    },
    "upside_score": {
      "points": 8,
      "best_rally_pct": 59.37,
      "reason": "Best rally of 59% gives 8/20 points"
    },
    "penalties": {
      "total": 0,
      "items": []
    }
  },
  "reasons_buy_sell": {
    "reasons_to_buy": [
      {
        "reason": "Early stage positioning offers best R:R if catalysts appear",
        "tag": "MED",
        "evidence": [
          "timing_regime=EARLY_BUILD",
          "current_return_pct=10.6%"
        ]
      },
      {
        "reason": "Proven winner - previously hit lock-in target",
        "tag": "MED",
        "evidence": [
          "lock_in_reached=True"
        ]
      }
    ],
    "reasons_to_sell": [
      {
        "reason": "Triangulation not loaded (RNS/social/trends missing)",
        "tag": "HIGH",
        "evidence": [
          "analysis_mode=HISTORICAL_ONLY",
          "confidence_capped_at_65"
        ]
      },
      {
        "reason": "Stale signal - not for active trading",
        "tag": "HIGH",
        "evidence": [
          "status=historical"
        ]
      }
    ]
  },
  "trade_plan": {
    "trader_plan": {
      "style": "Watch / Starter",
      "action": "Wait for base + catalyst confirmation; starter position only",
      "sizing": "0-1% until CONFIRMED",
      "risk": "Invalidation = breaks recent lows / dilution / suspension",
      "profit_taking": "Scale out 25% at +15%, 25% at +50%, runner above"
    },
    "investor_plan": {
      "allowed": false,
      "thesis_conditions": "Unlock after AI triangulation + CONFIRMED timing",
      "hold_window": "N/A",
      "risk_management": "N/A"
    }
  },
  "exhaustion": {
    "regime": "EARLY_BUILD",
    "run_multiple": 0.18,
    "current_run_pct": 10.62,
    "avg_historical_run_pct": 59.37
  },
  "history_snapshot": {
    "previous_report_date": null,
    "score_change": null,
    "confidence_change": null,
    "new_events_count": 0,
    "new_rns_titles": []
  },
  "commentary": {
    "executive_summary": "This report runs in HISTORICAL-ONLY mode: triangulation (RNS/social/trends) not loaded. The setup shows EARLY_BUILD timing with 55/100 APEX score. Historical data shows 3 rallies averaging 59% upside. Current position: +10.6%. Your edge comes from waiting for AI Engine confirmation instead of blind entry.",
    "bull_case": [
      "Early regime often offers best risk/reward"
    ],
    "bear_case": [
      "Monitor for breakdown signals"
    ],
    "timing_translation": "Early accumulation phase. Watch for confirmation before committing size.",
    "confidence_explained": "Confidence 45/100 reflects full data quality with triangulation loaded."
  },
  "data_quality": {
    "sources_present": {
      "snapshot_json": false,
      "daily_enrichment_row": true,
      "historical_profile": false,
      "metadata": true,
      "triangulation_events": true,
      "ai_insights": false
    },
    "missing_data": [
      "AI insights from Groq LLM"
    ],
    "confidence_impact": "HIGH",
    "disclaimer": "Data provided as-is. Not financial advice. AIM micro-caps carry significant volatility risk."
  }
}